Skip to main content
. Author manuscript; available in PMC: 2022 Jul 8.
Published in final edited form as: Surgery. 2020 Nov 19;169(4):963–973. doi: 10.1016/j.surg.2020.09.037

Table I.

Demographic, preoperative, surgical, and histopathological characteristics

Characteristic Overall (n = 153) NF-pNET (n = 61) Insulinoma (n = 92) P value
Age at pNET diagnosis in y, median [range] 36 [6–82] 40 [15–73] 32 [6–82] .002
 Missing data (%) 1 (1%) 0 (0%) 1 (1%)
Age at surgery in y, median [range] 38 [6–82] 41 [20–73] 34 [6–82] .002
Time from diagnosis until surgery in y, median [range] 0.5 [0–15] 0.5 [0–15] 0.3 [0–15] .006
 Missing data (%) 1 (1%) 0 1 (1%)
Sex (%)
 Male 66 (43%) 34 (56%) 32 (35%) .010
 Female 87 (57%) 27 (44%) 60 (65%)
Size largest pNET on preoperative imaging in mm, median [range] 20 [4–98] 27 [8–86] 20 [4–98] .009
 Missing data (%) 18 (12%) 5 (8%) 13 (14%)
Number of pNETs on preoperative imaging (%)
 0 5 (3%) 4 (7%) 1 (1%) .221
 1 71 (46%) 29 (48%) 42 (48%)
 2 29 (19%) 9 (15%) 20 (23%)
 ≥3 42 (28%) 18 (30%) 24 (28%)
 Missing data (%) 6 (4%) 1 (1%) 5 (5%)
Suspected lymph node metastases on preoperative conventional imaging (%) 5 (3%) 5 (8%) 0 (0%) .009
 Missing data (%) 1 (1%) 0 1 (1%)
Type of resection (%)
 Enucleation 23 (15%) 9 (15%) 14 (15%) -
 Multiple enucleations 6 (4%) 2 (3%) 4 (4%)
 Distal pancreatectomy 71 (46%) 33 (54%) 38 (41%)
 Distal pancreatectomy and enucleation 27 (18%) 2 (3%) 25 (27%)
 Whipple or PPPD 10 (7%) 5 (8%) 5 (5%)
 Whipple/PPPD and enucleation 2 (1%) 0 (0%) 2 (2%)
 Whipple/PPPD and distal pancreatectomy 5 (3%) 3 (5%) 2 (2%)
 Pancreatic body resection 1 (1%) 1 (2%) 0 (0%)
 Total pancreatectomy 8 (5%) 6 (10%) 2 (2%)
Combined resection (%) 40 (26.1%) 7 (12%) 33 (36%) .001
Number of pNETs in the resection specimen (%)
 1 39 (26%) 18 (30%) 21 (24%) .100
 2 27 (18%) 15 (25%) 12 (14%)
 ≥3 83 (56%) 28 (46%) 55 (63%)
 Missing data (%) 3 (2%) 0 (0%) 4 (4%)
Size largest pNET pathology in mm, median [range] 20 [3–120] 25 [3–120] 20 [5–110] .045
 Missing data (%) 13 (8%) 3 (5%) 10 (11%)
Lymph node metastases (%)
 Lymph node metastases 22 (14%) 18 (30%) 4 (4%) < .001
 No lymph node metastases 51 (33%) 14 (23%) 37 (40%)
 No lymph nodes resected 61 (40%) 29 (48%) 32 (35%)
 Missing data (%) 19 (12%) 0 (0%) 19 (21%)
WHO grade
 G1 87 (78%) 45 (79%) 42 (76%) .539
 G2 24 (21%) 11 (19%) 13 (24%)
 G3 1 (1%) 1 (2%) 0
 Missing data (%) 41 (27%) 4 (7%) 37 (40%)

PPPD, pylorus-preserving pancreatoduodenectomy.